Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Ethics declarations Competing interests SJW is the founder of Ridgeline Therapeutics, HN is a paid employee of Ridgeline Therapeutics and, since manuscript submission, ADW has also become a paid employee of Ridgeline Therapeutics
Human chimeric antigen receptor (CAR)-Tregs targeting OX40L for treatment of systemic lupus erythematosus [abstract]
An IFNgamma/STAT1/JMJD3 axis induces ZEB1 expression and promotes aggressiveness in lung adenocarcinoma
A lot of the enthusiasm around subcutaneous use comes from the idea that healing support may not need to stay local
US$ 27.12
US$ 21.04
.png)
US$ 23.45
US$ 25.93
US$ 24.20
